Please provide your email address to receive an email when new articles are posted on . Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) is an option after any intraocular surgery ...
FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...
Cataract surgery remains one of the most frequently performed ophthalmic procedures worldwide, with continual refinements in surgical methods and intraocular lens (IOL) technology contributing to ...
In this podcast, experts Tanner Ferguson, MD, and Taj Nasser, MD, FWCRS, discuss the management of astigmatism at the time of ...
Most people have a relative, friend or neighbor who has had to deal with a cataract. Nearly 24.5 million Americans age 40 or older are affected by cataracts, and it’s the leading cause of blindness ...
Controlling inflammation after cataract surgery is of paramount importance, and this is just as much the case for routine low-risk surgeries as it is for complicated or high-risk procedures. Patients ...
Among children who underwent unilateral cataract removal in infancy, risk of glaucoma-related adverse events continues to increase with longer follow-up and is not associated with primary intraocular ...
Sympathetic ophthalmia (SO) is a rare bilateral granulomatous uveitic condition that occurs after an inciting event to one eye, most commonly ocular trauma or intraocular surgery. A study by Hashimoto ...
The electromagnetic driving systems are proposed for the flexible 5-DOF magnetic manipulation of a micro-robot within the posterior eye, enabling precise targeted drug delivery. A research team has ...
CPT copyright 2011 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association. Editor’s Note: This article ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback